Medical Care Technologies (OTC Pink:MDCE) Secures Access to One of the World's Largest Public Skin Cancer Image Databases to Accelerate AI Development

Rhea-AI Summary

Medical Care Technologies (OTC Pink:MDCE) has secured access to the International Skin Imaging Collaboration (ISIC) Archive, one of the world's largest public skin cancer image databases. The archive contains over 70,000 dermoscopic images with expert annotations across various skin tones and cancer types.

This database will be used to train MDCE's AI software for detecting and classifying melanoma and other skin cancers. With skin cancer being the most common cancer globally (1.5 million new cases annually), this development aims to improve early detection capabilities worldwide.

The company is currently integrating the ISIC data into its machine learning pipeline and exploring additional collaborations to expand its training image database as it progresses toward clinical trials and commercialization.

Positive

• Access secured to prestigious ISIC Archive with 70,000+ expert-annotated dermoscopic images
• Strategic positioning for development of AI-driven skin cancer detection software
• Addresses large market opportunity with skin cancer being most common cancer globally (1.5M new cases/year)
• Positions company for future clinical trials and commercialization pathway

Negative

• Early stage development with no immediate revenue generation
• Clinical trials and regulatory approvals still pending
• Commercialization timeline undefined

MESA, ARIZONA / ACCESS Newswire / October 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging developer of advanced healthcare AI solutions, today announced that it has secured access to the International Skin Imaging Collaboration (ISIC) Archive - one of the world's largest publicly available, biopsy-verified image repositories for skin cancer and related dermatological conditions.

The ISIC Archive contains more than 70,000 high-quality, expertly annotated dermoscopic images, representing a wide range of skin tones, cancer subtypes, and benign conditions. This unprecedented data resource will serve as a foundation for training MDCE's proprietary AI software designed to detect and classify melanoma and other skin cancers at a level approaching clinical accuracy.

"The medical AI community has long recognized the ISIC Archive as a gold standard for dermatology research," said Marshall Perkins III, CEO of Medical Care Technologies. "By leveraging this highly respected and globally validated dataset, MDCE is advancing its mission to make early detection of skin cancer faster, more accurate, and more accessible worldwide."

Skin cancer is the most common cancer globally, with more than 1.5 million new cases diagnosed each year. Early detection dramatically improves patient outcomes, but access to dermatologists and specialized diagnostic tools remains limited in many parts of the world.

MDCE's development program is currently focused on integrating the ISIC data into its machine learning pipeline, with additional collaborations under review to further expand the diversity and scope of training images.

This milestone positions Medical Care Technologies to progress toward future clinical trials, regulatory pathways, and eventual commercialization of its AI-driven diagnostic platform.

Company Website: www.medicalcaretechnologies.com

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink:MDCE) is a healthcare technology company dedicated to developing innovative medical software solutions that improve early disease detection and patient care outcomes. The company is currently advancing an artificial intelligence platform for skin cancer and dermatological condition identification.

Safe Harbor Statement
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, projections, and assumptions that involve risks and uncertainties which may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What is the significance of MDCE's access to the ISIC Archive for skin cancer detection?

The ISIC Archive provides MDCE with over 70,000 high-quality, expert-annotated dermoscopic images to train their AI software for skin cancer detection, representing a crucial dataset for developing accurate diagnostic capabilities.

How many skin cancer cases occur globally according to MDCE's press release?

According to the press release, skin cancer is the most common cancer globally with more than 1.5 million new cases diagnosed each year.

What is Medical Care Technologies (MDCE) current development focus?

MDCE is currently focused on integrating the ISIC data into its machine learning pipeline and exploring additional collaborations to expand its training image database for AI-driven skin cancer detection.

What are the next steps for MDCE's AI skin cancer detection platform?

MDCE is progressing toward future clinical trials, regulatory pathways, and eventual commercialization of its AI-driven diagnostic platform.

How will MDCE's AI technology benefit skin cancer detection?

The technology aims to make skin cancer detection faster, more accurate, and more accessible worldwide, particularly important given limited access to dermatologists in many regions.